Text Size
93 studies found for:    Lung Transplant | Open Studies | NIH, U.S. Fed

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Viral Triggers in Pediatric Lung Transplantation
Conditions: Lung Transplant;   Bronchiolitis Obliterans;   Obliterative Bronchiolitis
Intervention:
2 Recruiting Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Constructive Bronchiolitis;   Graft Versus Host Disease
Intervention: Drug: Inhaled Cyclosporine Solution
3 Recruiting Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Graft vs Host Disease
Intervention: Drug: Cyclosporine Inhalation Solution
4 Unknown † Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
Conditions: Primary Graft Dysfunction;   Lung Transplantation
Intervention:
5 Unknown † Identifying Genetic Characteristics That Increase the Risk of Developing Primary Graft Dysfunction Following Lung Transplantation
Conditions: Primary Graft Dysfunction;   Lung Transplantation
Intervention:
6 Recruiting RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol
Conditions: Reflux;   Gastroesophageal Reflux Disease (GERD)
Intervention:
7 Not yet recruiting Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Cystic Fibrosis;   Pulmonary Fibrosis;   Bronchiectasis;   Sarcoidosis;   Pulmonary Hypertension;   Alpha-1 Antitrypsin Deficiency
Interventions: Procedure: Transplantation of lungs obtained from Non-Heart-Beating Donors (NHBDs) after ex-vivo perfusion w/ STEEN Solution™;   Device: STEEN Solution™
8 Not yet recruiting Cromolyn Detection of Silent Aspiration
Conditions: Gastroesophageal Reflux;   Respiratory Aspiration;   Idiopathic Pulmonary Fibrosis;   Lung Transplantation
Intervention: Drug: Cromolyn Sodium
9 Recruiting Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention:
10 Recruiting Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizer
11 Recruiting Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Behavioral: pulmonary rehabilitation
12 Recruiting Montelukast to Treat Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Chronic Graft Versus Host Disease;   Leukotriene;   Montelukast;   Stem Cell Transplant
Interventions: Drug: Montelukast sodium;   Other: Flow cytometry;   Other: Laboratory biomarker analysis;   Procedure: Quality-of-life assessment
13 Recruiting Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Conditions: Stem Cell Transplantation;   Transplantation, Homologous;   Allogenic Stem Cell Transplant Recipient
Intervention:
14 Recruiting CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
Condition: Acute Lung Injury
Interventions: Drug: Calfactant;   Other: Air placebo
15 Recruiting Screening for Subjects to Participate in Studies of Blood Disorders
Conditions: Bone Marrow Transplant;   Sickle Cell Disease
Intervention:
16 Unknown † Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Procedure: Hematopoietic Cell Transplantation
17 Recruiting Scleroderma Treatment With Autologous Transplant (STAT) Study
Condition: Systemic Scleroderma
Interventions: Procedure: peripheral blood stem cell transplantation;   Drug: cyclophosphamide;   Biological: anti-thymocyte globulin;   Other: questionnaire administration;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Biological: filgrastim;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: mycophenolate mofetil
18 Recruiting Fluticasone Propionate, Azithromycin, and Montelukast Sodium in Treating Patients With Bronchiolitis Obliterans Who Previously Underwent Stem Cell Transplant
Condition: Bronchiolitis Obliterans
Interventions: Drug: fluticasone propionate;   Drug: montelukast sodium;   Procedure: pulmonary function testing;   Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis;   Genetic: protein analysis;   Drug: azithromycin
19 Recruiting Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia
Conditions: Peripheral Blood Stem Cell Transplantation;   Anemia, Sickle Cell;   Graft-Versus-Host Disease;   Sirolimus (Rapamune(Registered Trademark));   Alemtuzumab (Campath(Registered Trademark))
Interventions: Procedure: PBMC Transplant;   Drug: Alemtuzumab (Campath(Registered Trademark));   Drug: Sirolimus (Rapamune(Registered Trademark));   Drug: Cyclophosphamide (Cytoxan(Registered Trademark));   Procedure: Low Dose Irradiation
20 Recruiting Transplants With Unlicensed Preserved Cord Blood
Conditions: Myelodysplastic Syndrome (MDS);   Hematologic Neoplasms;   Hematologic Diseases;   Severe Aplastic Anemia
Intervention: Procedure: Cord Blood Transplant
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years